Procyon Corp. | Cash Flow

Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
104.30
23.60
218.30
109.60
12.40
255.70
Depreciation, Depletion & Amortization
32.50
32.80
35.90
37.70
45.70
47.90
Other Funds
0.80
0.60
12.90
4.50
2.70
1.30
Funds from Operations
19.00
101.10
290.70
223.40
77.40
176.80
Changes in Working Capital
32.40
280.60
101.30
204.70
122.10
90.30
Net Operating Cash Flow
13.40
179.50
392.00
18.70
199.60
86.50
Capital Expenditures
12.50
10.50
66.50
73.30
35.90
Purchase/Sale of Investments
-
-
-
-
79.10
Net Investing Cash Flow
12.50
10.50
66.50
207.10
43.20
Issuance/Reduction of Debt, Net
108.50
-
80.00
43.30
128.80
Net Financing Cash Flow
108.50
-
80.00
43.30
128.80
Net Change in Cash
134.30
190.00
378.50
145.10
114.00
Free Cash Flow
25.90
190.00
458.60
54.60
180.70
Deferred Taxes & Investment Tax Credit
91.60
45.30
121.20
80.60
16.60
383.40
Other Sources
-
-
-
56.20
-
Other Uses
-
-
-
190.00
-

About Procyon

View Profile
Address
1300 South Highland Avenue
Clearwater Florida 33756
United States
Employees -
Website http://procyoncorp.com
Updated 07/08/2019
Procyon Corp. is a holding company, which engages in the development and marketing of proprietary medical products. Its products include AMERX, AMERIGEL, and HELIX3 Bioactive Collagen. The company was founded on March 19, 1987 and is headquartered in Clearwater, FL.